PyInvesting

Market research

000756.SHE Shandong Xinhua Pharmaceutical Company Limited

SHE CNY Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
9B
P/E ratio
34.79
Analyst target
10.5
Dividend yield
1.0%
Beta
-0.02

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Shandong Xinhua Pharmaceutical Company Limited is currently in a long term downtrend where the price is trading 8.5% below its 200 day moving average.

From a valuation standpoint, the stock is 90.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.

Shandong Xinhua Pharmaceutical Company Limited's total revenue rose by 13.3% to $1B since the same quarter in the previous year.

Its net income has increased by 28.4% to $79M since the same quarter in the previous year.

Finally, its free cash flow fell by 948.0% to $-64M since the same quarter in the previous year.

Based on the above factors, Shandong Xinhua Pharmaceutical Company Limited gets an overall score of 3/5.